Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

EU Recommends Approval for Alexion's Rare Disease Drugs

June 29, 2015 8:26 am | News | Comments

The drugs are called Strensiq and Kanuma. Read more...

TOPICS:

Allergan Layoffs Done at Irvine Location; Kythera Cuts in Question

June 26, 2015 1:35 pm | by Ryan Bushey, Associate Editor | Articles | Comments

The CEO of Allergan discussed the future of his company after the completion of the Actavis merger. Read more...

TOPICS:

Drug Discovery Spotlight: ASCO’s Cancer Drugs Rating Scale; Hepatitis C Drug Patent Rejected in China

June 26, 2015 12:59 pm | by Stephanie Guzowski, Editor | News | Comments

The American Society of Clinical Oncology said it would provide a rating scale for cancer drugs, and now it’s delivered — and not all the score results are assuring. Pharma’s next five years look promising, according to an industry report. Read more...

TOPICS:
Advertisement

California Vaccine Bill Clears Legislative Hurdle

June 26, 2015 10:43 am | by Seth Augenstein, Digital Reporter | News | Comments

A split California Assembly approved a bill that would require nearly all public school kids to get basic vaccines Thursday. The bill passed on a bipartisan 46 to 30 vote and, if signed by the governor, would give California one of the strictest vaccine requirements, by eliminating the “personal belief” exemption used by anti-vaccine parents. Read more...

TOPICS:

Janssen Schizophrenia Treatment Now Commercially Available

June 26, 2015 10:37 am | News | Comments

The first schizophrenia treatment to be taken just four times a year – with dosing measured in seasons, not days – is now available in the United States. The three-month dosing interval of Invega Trinza (paliperidone palmitate) offers a new paradigm for treating patients with schizophrenia. Read more...

TOPICS:

Delivering Drugs to the Right Place

June 26, 2015 9:27 am | by UC Santa Barbara | News | Comments

For the 12 million people worldwide who suffer from polycystic kidney disease (PKD), an inherited disorder with no known cure, a new treatment option may be on the horizon. Read more...

TOPICS:

Alzheimer’s Expert Jams with Aerosmith

June 26, 2015 8:59 am | by Bevin Fletcher, Associate Editor | News | Comments

One of the world’s leading Alzheimer’s researchers doubles as a guest organist for Aerosmith. Rudy Tanzi, Ph.D., the Kennedy professor of neuroscience at Harvard, hit it off with lead guitarist Joe Perry on a photo shoot for men’s fashion magazine GQ, and the scientist, who is an expert on how beta amyloid accumulates in the brain, has since played with the band on a number of special occasions, CNN reported. Read more...

TOPICS:

Human Trials of Manufactured Blood within Two Years

June 26, 2015 8:34 am | by University of Bristol | News | Comments

The clinical trial of manufactured red blood cells is designed to compare the survival of red cells manufactured from stem cells with that of standard blood donor red blood cells. Read more...

TOPICS:
Advertisement

French Senators Reject Bill on Sedating Terminal Patients

June 26, 2015 8:34 am | by The Associated Press | News | Comments

Senators in Paris rejected the law by a vote of 196-87. Read more...

TOPICS:

Cancer Drug Makes Fruit Flies Live Longer

June 26, 2015 8:33 am | by University College London | News | Comments

The drug targets a specific cellular process that occurs in animals, including humans, delaying the onset of age-related deaths by slowing the ageing process. Read more...

TOPICS:

Melatonin Offers Hope for ADHD Bedtime Shut-Eye

June 26, 2015 8:32 am | by University of Queensland | News | Comments

Researchers are recruiting trial participants for a study investigating the effectiveness of the natural hormone melatonin on children with ADHD who are struggling to settle at bedtime. Read more...

TOPICS:

Breast Cancer Paper to Be Retracted– 3 Years After False Data Exposed

June 26, 2015 8:31 am | by Seth Augenstein, Digital Reporter | News | Comments

An academic paper that outlined how breast cancer molecules metastasize will be retracted next week, because of falsified data. Read more...

TOPICS:

Global Gene Therapy Deals Sky-Rocketed to Nearly $5B in 2014

June 26, 2015 8:31 am | by Adam Dion, MS, Senior Industry Analyst, GlobalData | Articles | Comments

Nearly $1.5 billion was raised in the gene therapy arena from 2014 to 2015. Read more...

TOPICS:

Eli Lilly Wins U.K. Alimta Drug Patent Case

June 25, 2015 1:22 pm | by Stephanie Guzowski, Editor | News | Comments

Eli Lilly won a patent case in the U.K. that prohibits competitors from manufacturing a generic form of its blockbuster Alimta lung cancer drug before the patent expires in 2021. Read more...

TOPICS:

Medical Research Not Addressing Patient, Clinician Priorities

June 25, 2015 12:37 pm | by BioMed Central | News | Comments

Research on treatments for health problems, such as diabetes, stroke and schizophrenia, is not being focused on the treatments considered most important by patients and clinicians, according to a study published in the open access journal Research Involvement and Engagement. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading